French microbiologist Didier Raoult on Friday released some early results from his treatment of 1061 coronavirus patients with a combination of hydroxychloroquine and the antibiotic azithromycin.
Raoult says the treatment had a good outcome in 91.7 percent of patients, a poor virological
outcome in 4.4 percent (viral shedding persistence at day 10) and a poor clinical outcome in 4.3 percent (either death or transfer to intensive care unit or hospitalization for 10 days or more).
He says 98 percent were eventually cured.
There were 5 deaths….